FONTANEX: Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation

Sponsor
Swiss Federal Institute of Technology (Other)
Overall Status
Recruiting
CT.gov ID
NCT04151004
Collaborator
(none)
40
1
2
37.9
1.1

Study Details

Study Description

Brief Summary

Congenital heart disease (CHD) is the most common congenital defect, affecting about 1% of newborns. Among adults surviving complex CHD, the cohort of survivors after the Fontan palliation for univentricular physiology is the most rapidly growing. Given their unique physiology without a pumping chamber supporting the pulmonary circulation, their exercise capacity as adults is often severely reduced. Therefore, patients with grown-up CHD typically need long-term expert medical care causing constantly increasing healthcare- related costs. Specific exercise regimes might offer a safe, efficacious and cost-effective alternative to pharmacologic interventions and surgery. The underlying mechanisms of impaired exercise capacity in Fontan patients are, however, not fully understood and consequently, training regimes specifically tackling the limiting factors cannot be developed. In patients with CHD, studies have suggested that exercise limitations are secondary to the cardiac defects, factors related to cardiac surgery, chronotropic incompetence and underlying lung disease. Similar to heart failure patients, exercise limitations could be traced back to insufficient respiratory and leg muscle functions and impaired cardiovascular regeneration processes possibly due to an altered stem cell number and function in the peripheral blood.

The present study will investigate cardiac, respiratory and quadriceps muscle function at rest and during submaximal and maximal whole-body exercises. A special focus will be given on respiratory and quadriceps muscle strength, and proneness of these muscles to fatigue, which has not yet been objectively investigated. Moreover, different respiratory muscle training (RMT) protocols will be executed, to assess the safety of these interventions. Moreover, the current study will be the first to investigate the influence of exhaustive exercise protocols on the number and function of circulating stem and progenitor cells (CPCs) in Fontan patients. The number of these cell populations was shown to strongly correlate with long-term outcome and recovery in several diseases. This study aims to reveal whether Fontan patients show similarly alternated stem cell number and function in the peripheral blood, that likely result in impaired vascular regeneration processes and possibly also contribute to reduced exercise capacity.

Condition or Disease Intervention/Treatment Phase
  • Other: Incremental cycling test (ICT)
  • Other: Constant load cycling test (CET)
  • Other: Incremental respiratory muscle test (IncRMET)
  • Other: Incremental quadriceps muscle test (IncQMT)
  • Other: Respiratory muscle training like interventions
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation
Actual Study Start Date :
Nov 4, 2019
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patient group

Incremental cycling test to volitional exhaustion. Constant load cycling test to volitional exhaustion. Respiratory and leg muscle endurance test to volitional exhaustion. Three respiratory muscle training interventions.

Other: Incremental cycling test (ICT)
Incremental cycling test to volitional exhaustion

Other: Constant load cycling test (CET)
Constant load cycling test to volitional exhaustion.

Other: Incremental respiratory muscle test (IncRMET)
Incremental respiratory muscle test to volitional exhaustion.

Other: Incremental quadriceps muscle test (IncQMT)
Incremental quadriceps muscle test to volitional exhaustion.

Other: Respiratory muscle training like interventions
Three different respiratory muscle training like interventions that are usually used for respiratory muscle trainings.

Active Comparator: Control group

The control group executes the same tests as the patient group.

Other: Incremental cycling test (ICT)
Incremental cycling test to volitional exhaustion

Other: Constant load cycling test (CET)
Constant load cycling test to volitional exhaustion.

Other: Incremental respiratory muscle test (IncRMET)
Incremental respiratory muscle test to volitional exhaustion.

Other: Incremental quadriceps muscle test (IncQMT)
Incremental quadriceps muscle test to volitional exhaustion.

Other: Respiratory muscle training like interventions
Three different respiratory muscle training like interventions that are usually used for respiratory muscle trainings.

Outcome Measures

Primary Outcome Measures

  1. Change in respiratory muscle strength (in cmH2O) [At baseline and after acute exercise (approximately 15 minutes)]

    Change in respiratory muscle strength will be measured between baseline and after an acute exercise

  2. Change in quadriceps muscle strength (in Newton) [At baseline and after acute exercise (approximately 15 minutes)]

    Change in quadriceps muscle strength will be measured between baseline and after an acute exercise

Secondary Outcome Measures

  1. Change in ventilation (in liter per minute) [On visit 1at baseline and after acute exercise (approximately 15 minutes)]

    Change in ventilation will be measured between baseline and after an acute exercise

  2. Change in gas exchange (in liter per minute) [At baseline and after acute exercise (approximately 15 minutes)]

    Change in gas exchange will be measured between baseline and after an acute exercise

  3. Change in heart rate (beats per minute) [At baseline and after acute exercise (approximately 15 minutes)]

    Change in heart rate will be measured between baseline and after an acute exercise

  4. Change in cardiac output (in liter per minute) [At baseline and after acute exercise (approximately 15 minutes)]

    Change in cardiac output will be measured between baseline and after an acute exercise

  5. Change in blood pressure (in mmHg) [At baseline and after acute exercise (approximately 15 minutes)]

    Change in cardiac output will be measured between baseline and after an acute exercise

  6. Change in blood oxygen saturation (in %) [At baseline and after acute exercise (approximately 15 minutes)]

    Change in blood oxygen saturation will be measured between baseline and after an acute exercise

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age: 18 - 55 years

  • Fontan palliation (for Fontan patients)

  • NYHA I - III (for Fontan patients)

  • Willing to adhere to the study rules

Exclusion Criteria:
  • NYHA IV (for Fontan patients)

  • not being able to perform cycle exercise

  • known diaphragmatic paresis

  • being pregnant or breast feeding

  • Intention to become pregnant during the course of the study

  • known or suspected non-compliance, drug or alcohol abuse

  • Regular intake of medication affecting sleep or the performance of the respiratory, cardiovascular or neuromuscular system (except for Fontan-related medication for patients)

  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

  • previous enrolment in current study

  • being investigator or his/her family member, employee or another dependent person

Contacts and Locations

Locations

Site City State Country Postal Code
1 Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich Zürich ZH Switzerland 8057

Sponsors and Collaborators

  • Swiss Federal Institute of Technology

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Swiss Federal Institute of Technology
ClinicalTrials.gov Identifier:
NCT04151004
Other Study ID Numbers:
  • FONTANEX_2019
First Posted:
Nov 5, 2019
Last Update Posted:
Jul 7, 2021
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 7, 2021